Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 14
2003 13
2004 17
2005 14
2006 14
2007 26
2008 21
2009 16
2010 27
2011 28
2012 34
2013 29
2014 41
2015 36
2016 47
2017 42
2018 41
2019 47
2020 57
2021 52
2022 47
2023 37
2024 47
2025 46
2026 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

770 results

Results by year

Filters applied: . Clear all
Page 1
Coronary Artery Anomalies.
Gentile F, Castiglione V, De Caterina R. Gentile F, et al. Among authors: de caterina r. Circulation. 2021 Sep 21;144(12):983-996. doi: 10.1161/CIRCULATIONAHA.121.055347. Epub 2021 Sep 20. Circulation. 2021. PMID: 34543069 Free article. Review.
Asundexian versus Apixaban in Patients with Atrial Fibrillation.
Piccini JP, Patel MR, Steffel J, Ferdinand K, Van Gelder IC, Russo AM, Ma CS, Goodman SG, Oldgren J, Hammett C, Lopes RD, Akao M, De Caterina R, Kirchhof P, Gorog DA, Hemels M, Rienstra M, Jones WS, Harrington J, Lip GYH, Ellis SJ, Rockhold FW, Neumann C, Alexander JH, Viethen T, Hung J, Coppolecchia R, Mundl H, Caso V; OCEANIC-AF Steering Committee and Investigators. Piccini JP, et al. Among authors: de caterina r. N Engl J Med. 2025 Jan 2;392(1):23-32. doi: 10.1056/NEJMoa2407105. Epub 2024 Sep 1. N Engl J Med. 2025. PMID: 39225267 Clinical Trial.
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.
Rashedi S, Leyva H, Hamade N, Pfeferman MB, Ortega-Paz L, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Lang IM, Weitz JI, Goldhaber SZ, De Caterina R, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B. Rashedi S, et al. Among authors: de caterina r. J Am Coll Cardiol. 2025 Oct 7;86(14):1065-1087. doi: 10.1016/j.jacc.2025.07.061. J Am Coll Cardiol. 2025. PMID: 41033744 Review.
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
Mackenzie IS, Ford I, Nuki G, Hallas J, Hawkey CJ, Webster J, Ralston SH, Walters M, Robertson M, De Caterina R, Findlay E, Perez-Ruiz F, McMurray JJV, MacDonald TM; FAST Study Group. Mackenzie IS, et al. Among authors: de caterina r. Lancet. 2020 Nov 28;396(10264):1745-1757. doi: 10.1016/S0140-6736(20)32234-0. Epub 2020 Nov 9. Lancet. 2020. PMID: 33181081 Free article. Clinical Trial.
ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy. Agewall S, et al. Among authors: de caterina r. Eur Heart J. 2017 Jan 14;38(3):143-153. doi: 10.1093/eurheartj/ehw149. Eur Heart J. 2017. PMID: 28158518 Free article. No abstract available.
The Reply.
Tamborrino PP, De Caterina R. Tamborrino PP, et al. Among authors: de caterina r. Am J Med. 2024 Jul;137(7):e131-e132. doi: 10.1016/j.amjmed.2024.03.009. Am J Med. 2024. PMID: 38942489 No abstract available.
770 results